SyntekaBio (XKRX:226330) YoY EBITDA Growth

: -219.25% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SyntekaBio's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -219.25%.

SyntekaBio's EBITDA per Share for the three months ended in Dec. 2023 was ₩-820.95.

SyntekaBio YoY EBITDA Growth Historical Data

The historical data trend for SyntekaBio's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-529.07

81.76

-146.32

86.76

-391.04

SyntekaBio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth																58.77	-1,434.53	-120.62	374.93	-219.25

SyntekaBio YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SyntekaBio's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-646.686	-	-131.696)	/	\| -131.696 \|
=	-391.04 %

SyntekaBio's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-820.95	-	-257.148)	/	\| -257.148 \|
=	-219.25 %

SyntekaBio YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of SyntekaBio's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SyntekaBio (XKRX:226330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512

Website

http://www.syntekabio.co.kr

SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio (XKRX:226330) Headlines

No Headlines